Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Elcelyx Therapeutics
11995 El Camino Real, Suite 305
San Diego, CA 92130
Phone: 858-876-1814
www.elcelyx.com

Elcelyx Therapeutics is developing ultra-safe products for weight management and obesity-related metabolic disorders based on the science of nutrient sensing. The Elcelyx first-in-class product candidates, Lovidia(TM) and NewMet(TM), are Gut Sensory Modulators backed by rigorous science and clinical data demonstrating their ability to rapidly reduce weight and improve glucose metabolism without systemic side effects, respectively. The products represent reduced-risk, near-term blockbuster opportunities in weight management and Type 2 diabetes with longer-term opportunities in obesity and prediabetes.

Key Contact
Name
Alain Baron, M.D.
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
08/13/12 $4,000,000 Series B Morgenthaler
Technology Partners
undisclosed
02/14/13 $20,000,000 Series C GSM Fund
Morgenthaler
Technology Partners
undisclosed
10/01/15 $40,000,000 Series E Clough Capital Partners
GSM Fund
Morgenthaler
Sailing Capital
Technology Partners
undisclosed


Featured Reading